NC
SRRA

Nexthera Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Nexthera Capital’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,000
Closed -$468K – 50
2017
Q2 		$468K Hold
10,000
– – 0.2% 38
2017
Q1 		$612K Buy
+10,000
New +$581K 0.31% 31
2016
Q1 		– Sell
-500
Closed -$301K – 47
2015
Q4 		$301K Buy
+500
New +$338K 0.43% 31

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Nexthera Capital's SRRA Position: Q3 2017 in Review

Nexthera Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2017, closing a stake of 10,000 shares — an estimated $468K sold.

Nexthera Capital first reported a position in SRRA in Q4 2015 and held it in 3 quarters. The position peaked at $612K in Q1 2017. 41 funds tracked by Wall St. Rank hold SRRA as of Q3 2017.

  • Nexthera Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Nexthera Capital sold 10,000 Sierra Oncology, Inc. Common Stock shares in Q3 2017, an estimated $468K.
  • Nexthera Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 3 quarters.
  • Nexthera Capital's Sierra Oncology, Inc. Common Stock position peaked at $612K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2017.

Based on Nexthera Capital's 13F filing for Q3 2017, filed 14 Nov 2017.